My ePortfolio Register   

Abstract | Full HTML Article | PDF ecancer 10 611 /

Conference Report

Drug-drug interactions in older patients with cancer: a report from the 15th Conference of the International Society of Geriatric Oncology, Prague, Czech Republic, November 2015

Drugs taken for cancer can interact with each other, with agents taken as part of supportive care, with drugs taken for comorbid conditions (which are particularly common in the elderly patients), and with herbal supplements and complementary medicines. We tend to focus on the narrow therapeutic window of cytotoxics, but the metabolism of tyrosine kinase inhibitors by the cytochrome P450 3A4 enzyme (CYP3A4) makes some TKIs particularly prone to interference with or from other agents sharing this pathway. There is also potential for adverse pharmacokinetic interactions with new hormonal agents used in advanced prostate cancer.

Keywords: elderly, cancer, polypharmacy, drug interaction, adverse drug events, tyrosine kinase inhibitors, SIOG

Loading Article Metrics ... Please wait

Related videos

Related articles

Research: Diagnostic validity of fine-needle capillary cytology in palpable tumours at the Oncology Institute of Peru

Abstract | Full Article | PDF | Spanish Published: 01 Feb 2018 /

Research: Men seeking counselling in a Breast Cancer Risk Evaluation Clinic

Abstract | Full Article | PDF Published: 30 Jan 2018 /

Review: A systematic review of the literature exploring the interplay between prostate cancer and type two diabetes mellitus

Abstract | Full Article | PDF Published: 25 Jan 2018 /

Review: Natural history of castration-resistant prostate cancer in sub-Saharan African black men: a single-centre study of Nigerian men

Abstract | Full Article | PDF Published: 16 Jan 2018 /

Case Report: Primary non-Hodgkin lymphoma of the prostate: a case report

Abstract | Full Article | PDF Published: 12 Dec 2017 /

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence